Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.42−0.02 (-0.27%)
Close on Nov 13, 2026Market cap $271.07MP/E –Yield –
Profound Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Profound Medical's operating income for the twelve months ending Sep 30, 2026 was -$34.28M. For fiscal 2025 it was -$41.25M. The highest annual figure on record is -$14.90M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.25M | – |
| FY2024 | Dec 31, 2024 | -$33.06M | – |
| FY2023 | Dec 31, 2023 | -$28.65M | – |
| FY2022 | Dec 31, 2022 | -$32.13M | – |
| FY2021 | Dec 31, 2021 | -$30.29M | – |
| FY2020 | Dec 31, 2020 | -$18.86M | – |
| FY2019 | Dec 31, 2019 | -$14.90M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$7.82M | – |
| Q2 FY2026 | Jun 30, 2026 | -$11.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.37M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.91M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$11.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.00M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.88M | – |
See a number that looks wrong?